Testing effectiveness (Phase 2)Ended earlyNCT01372813What this trial is testingVandetanib to Treat Advanced Kidney CancerWho this might be right forAdvanced Clear Cell Renal Carcinoma National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)Study completedNCT03617913What this trial is testingAvelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder CancerWho this might be right forBladder Carcinoma Infiltrating the Muscle of the Bladder WallStage II Bladder Cancer AJCC v8Stage II Renal Pelvis Cancer AJCC v8+9 more Mayo Clinic 2
Early research (Phase 1)Study completedNCT01352962What this trial is testingGemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid TumorsWho this might be right forUrethral NeoplasmsNeoplasms, UrethralCancer of the Urethra+1 more National Cancer Institute (NCI) 18
Not applicableStudy completedNCT00088803What this trial is testingDNA Variations in the Gene in Young Patients With Wilms' TumorWho this might be right forKidney Cancer Children's Oncology Group 471
Testing effectiveness (Phase 2)Study completedNCT00006486What this trial is testingCarboxyamidotriazole in Treating Patients With Metastatic Kidney CancerWho this might be right forRecurrent Renal Cell CancerStage IV Renal Cell Cancer National Cancer Institute (NCI) 335
Not applicableLooking for participantsNCT05060783What this trial is testingRenal Cancer Detection With Liquid BiopsyWho this might be right forRenal CancerOncocytoma Zealand University Hospital 200
Post-approval studies (Phase 4)Study completedNCT05293041What this trial is testingArgipressin's Influence on Blood Loss During Hepatic ResectionWho this might be right forColon Cancer Liver MetastasisInflammatory ResponseVasopressin Causing Adverse Effects in Therapeutic Use Kristina Svennerholm 248
Early research (Phase 1)Looking for participantsNCT07300241What this trial is testingOpen-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell CarcinomaWho this might be right forClear Cell Renal Cell CarcinomaRenal Cell CarcinomaRCC+6 more Neomorph, Inc 30
Not applicableStudy completedNCT04006405What this trial is testingAURORAX-0087A: GAG Scores for Surveillance of Recurrence in Leibovich Points ≥5 Non-metastatic ccRCCWho this might be right forClear Cell Renal Cell Carcinoma Elypta 280
Testing effectiveness (Phase 2)Study completedNCT03581773What this trial is testingFolic Acid Supplement Versus Placebo for Treating Mucositis Adverse Events in Metastatic Renal Cell Carcinoma Patients Receiving Targeted TherapyWho this might be right forMucositisStomatitis Niels Fristrup 84
Early research (Phase 1)Study completedNCT00931931What this trial is testingHSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid TumorsWho this might be right forRhabdomyosarcomaOsteosarcomaEwing Sarcoma+6 more Timothy Cripe 18
Testing effectiveness (Phase 2)Study completedNCT03149822What this trial is testingStudy of Pembrolizumab and Cabozantinib in Patients With Metastatic Renal Cell CarcinomaWho this might be right forMetastatic Renal Cell Carcinoma University of Colorado, Denver 45
Not applicableStudy completedNCT00080873What this trial is testingTraumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell TransplantationWho this might be right forKidney CancerLeukemiaLymphoma+3 more Children's Oncology Group 195
Testing effectiveness (Phase 2)Ended earlyNCT04871529What this trial is testingTesting the Addition of an Anti-Cancer Immunotherapy Drug, Avelumab, to Gemcitabine and Carboplatin Chemotherapy Prior to Surgery in Muscle Invasive Urinary Tract Cancer vs. Surgery Alone in Patients Who Are Not Able to Receive Cisplatin Therapy (SWOG GAP TRIAL)Who this might be right forBladder Carcinoma Infiltrating the Muscle of the Bladder WallInfiltrating Renal Pelvis and Ureter Urothelial CarcinomaStage II Bladder Cancer AJCC v8 SWOG Cancer Research Network 6
Testing effectiveness (Phase 2)Study completedNCT00005831What this trial is testingTrastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tract CancerWho this might be right forMetastatic Transitional Cell Cancer of the Renal Pelvis and UreterRecurrent Bladder CancerRecurrent Transitional Cell Cancer of the Renal Pelvis and Ureter+3 more National Cancer Institute (NCI) 40
Early research (Phase 1)Active Not RecruitingNCT04004442What this trial is testingAvelumab in Combination With AVB-S6-500 in Patients With Advanced Urothelial CarcinomaWho this might be right forUrothelial Carcinoma University of Oklahoma 19
Early research (Phase 1)Study completedNCT04504669What this trial is testingFirst Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid TumoursWho this might be right forClear Cell Renal Cell CancerNon-Small-Cell Lung CancerTriple Negative Breast Neoplasms+6 more AstraZeneca 60
Not applicableStudy completedNCT04213157What this trial is testingLaparoscopic Partial Nephrectomy for cT1 TumorsWho this might be right forRenal CancerRenal NeoplasmRenal Cell Carcinoma+10 more Samsun Liv Hospital 292
Early research (Phase 1)Study completedNCT00016237What this trial is testingInterleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous TreatmentWho this might be right forBladder CancerKidney CancerLung Cancer EMD Serono
Not applicableLooking for participantsNCT05403177What this trial is testingMarathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)Who this might be right forBreast CancerColorectal CancerPancreas Cancer+9 more University Health Network, Toronto 500